Kai Deusch
President at Medicis Capital GmbH
Profile
Dr. Kai Deusch is the Chairman of Medicis Capital GmbH.
He founded Medicis in 1994 when he was still in Academia.
Then, Medicis provided consulting and contract research services in pre-clinical and clinical drug development.
From 1999 on Medicis focused on principal investments and consulting services in healthcare transactions and business development.
The Founder is supported by a team of Partners located in Europe and in the USA.
Mr. Kai Deusch contributes more than twenty years professional experience in the Healthcare & Life Science Sector.
Initially he worked for more than ten years as a clinician and medical researcher at various international institutions and subsequently as a management consultant, Investor and entrepreneur.
Most recently, he has been a founding investor & CEO of a buy-out in the Medtech Sector based in Switzerland and the USA.
Prior to this he has been a partner at Apax Partners (2001-2002) with responsibility for the Healthcare Secctor in Germany, Austria and Switzerland, Partner in an intellectual property commercialisation firm and founder & CEO of a Biotech Venture Capital firm that he successfully sold in 2001, management consultant in the Healthcare Practice of McKinsey & Company (1996-1999) and an internist with specialization in hepatogastroenterology & immunology.
He focuses on transactions in the area of Healthcare Services & Care Provision, Medical Technologies, Pharmaceuticals, Biotech and other Life Sciences.
Mr. Kai Deusch studied Biology and Human Medicine at tthe Universities of Minneapolis, Mainz andLondon.
He earned a B.Sc.
in Biology , an MD (Dr. med.) in Human Medicine and qualified as a board certified Internist and an Associate Professor of Medicine (Privatdozent Dr. med.
Dr. med habil.) at Technical Univeristy in Munich.
Kai Deusch active positions
| Companies | Position | Start |
|---|---|---|
Medicis Capital GmbH
 Medicis Capital GmbH Investment ManagersFinance Medicis Capital GmbH is an independent German private equity firm which was founded by Kai Deusch in 1995 to provide consulting and contract research services in pre-clinical and clinical drug development. In 1999, Medicis began to focus on principal investments and consulting services in healthcare transactions and business development. Based in Munich, the firm and their network of associated partners provide a range of services around healthcare investing, business transactions and business development strategy. In 2007 Medicis formed a partnership with US-based Nexus Group, establishing a joint investment vehicle named Medicis Nexus. The partnership between Medicis and Nexus enables both firms to efficiently identify and manage their investments in Europe and the US. | President | 01/01/1994 |
Former positions of Kai Deusch
| Companies | Position | End |
|---|---|---|
RIEMSER Pharma GmbH
 RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Chief Executive Officer | 31/05/2015 |
Lab 21 Ltd.
 Lab 21 Ltd. Medical/Nursing ServicesHealth Services Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 03/05/2013 |
NuvoLase, Inc.
 NuvoLase, Inc. Medical SpecialtiesHealth Technology NuvoLase, Inc. develops light-based disinfectant devices and procedures. It offers FootLaser, a laser light-based device for the temporary increase of clear nail in patients with onychomycosis or nail fungus. The firm serves healthcare providers worldwide. The company was founded by John Strisower, David Michael Harris and Preston W. Campbell III in August 2011 and is headquartered in Chico, CA. | Director/Board Member | - |
MAST Biosurgery AG
 MAST Biosurgery AG Medical SpecialtiesHealth Technology MAST Biosurgery AG develops and markets advanced engineered composite materials. The firm’s products include surgiwrap bioresorbable sheet, orthowrap bioresorbable sheet and cardiowrap bioresorbable sheet. The company is headquartered in Zurich, Switzerland. | Chairman | - |
Training of Kai Deusch
| University of Minnesota | Undergraduate Degree |
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
RIEMSER Pharma GmbH
RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Health Technology |
Medicis Capital GmbH
Medicis Capital GmbH Investment ManagersFinance Medicis Capital GmbH is an independent German private equity firm which was founded by Kai Deusch in 1995 to provide consulting and contract research services in pre-clinical and clinical drug development. In 1999, Medicis began to focus on principal investments and consulting services in healthcare transactions and business development. Based in Munich, the firm and their network of associated partners provide a range of services around healthcare investing, business transactions and business development strategy. In 2007 Medicis formed a partnership with US-based Nexus Group, establishing a joint investment vehicle named Medicis Nexus. The partnership between Medicis and Nexus enables both firms to efficiently identify and manage their investments in Europe and the US. | Finance |
Lab 21 Ltd.
Lab 21 Ltd. Medical/Nursing ServicesHealth Services Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom. | Health Services |
MAST Biosurgery AG
MAST Biosurgery AG Medical SpecialtiesHealth Technology MAST Biosurgery AG develops and markets advanced engineered composite materials. The firm’s products include surgiwrap bioresorbable sheet, orthowrap bioresorbable sheet and cardiowrap bioresorbable sheet. The company is headquartered in Zurich, Switzerland. | Health Technology |
NuvoLase, Inc.
NuvoLase, Inc. Medical SpecialtiesHealth Technology NuvoLase, Inc. develops light-based disinfectant devices and procedures. It offers FootLaser, a laser light-based device for the temporary increase of clear nail in patients with onychomycosis or nail fungus. The firm serves healthcare providers worldwide. The company was founded by John Strisower, David Michael Harris and Preston W. Campbell III in August 2011 and is headquartered in Chico, CA. | Health Technology |
- Stock Market
- Insiders
- Kai Deusch
